As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.
Bird flu vaccine gets ‘conditional license’ from USDA, company announces
A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.
USDA grants conditional license for bird flu vaccine
In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due to the virus. This month, the USDA granted a conditional license to Zoetis for its Avian Influenza Vaccine.
Zoetis gets Conditional License for Bird Flu Vaccine
Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.
A bird flu vaccine for chickens is on its way
In a bid to contain a bird flu outbreak that has sent egg prices soaring, the U.S. Department of Agriculture (USDA) last week granted a conditional license for a vaccine designed to protect chickens from the virus.
Zoetis Inc. stock underperforms Friday when compared to competitors despite daily gains
This was the stock's third consecutive day of gains.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Why Zoetis Stock Took Another Tumble Today
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Yahoo Finance2d
Zoetis to Participate in Upcoming Investor Conferences
PARSIPPANY, N.J., February 20, 2025--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences.
Zoetis price target lowered to $200 from $225 at BTIG
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...